A novel approach to overactive bladder syndrome treatment

Affiliations

Paweł Szalecki. Cent European J Urol. 2014.

. 2014;67(1):49-50.

doi: 10.5173/ceju.2014.01.art10.

No abstract available

Comment on

1. Irvin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, et al. Population–based survey of urinary incontinence, overactive bladder and other lover urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50:1306–1314. - PubMed
1. Buser N, Ivic S, Kessler TM, Kessels AGH, Bachmann LM. Efficacy and adverse events of antimuscarnics for treating overactive bladder: network meta analises. Eur Urol. 2012;60:1040–1060. - PubMed
1. Sexton CC, Notte SM, Maroulis C, Dmochowski RR, Cardozo L, Subramanian D, Coyne KS. Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature. Int J Clin Pract. 2011;65:567–585. - PubMed
1. Kosilov KV, Lopaarev SV, Iwanowskaya MA, Kosilova LV. Effectiveness of Combined High–Dosed Trospium and Solifenacin depending on severity of OAB symptoms in elderly men and women under cyclic therapy. Cent European J Urol. 2014;67:43–48. - PMC - PubMed
1. Kosilov KV, Lopaarev SV, Ivanovskaya MA, Kosilova LV. Management of Overactive Bladder (OAB) in Elderly Men and Women with Combined, High–Dosed Antimuscarinics without Increased Side Effects. UroToday Int J. 2013;6 art 47.